<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Fertil Steril</journal-id><journal-id journal-id-type="iso-abbrev">Int J Fertil Steril</journal-id><journal-id journal-id-type="publisher-id">Royan Institute</journal-id><journal-title-group><journal-title>International Journal of Fertility &#x00026; Sterility</journal-title></journal-title-group><issn pub-type="ppub">2008-076X</issn><issn pub-type="epub">2008-0778</issn><publisher><publisher-name>Royan Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24520435</article-id><article-id pub-id-type="pmc">3850306</article-id><article-id pub-id-type="other">Int-J-Fertil-Steril-6-175</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject><subj-group><subject>Gynecology and Female Infertility</subject><subject>Embryology</subject></subj-group></subj-group></article-categories><title-group><article-title>Effect of Adding Human Chorionic Gonadotropin to The Endometrial
Preparation Protocol in Frozen Embryo Transfer Cycles</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Eftekhar</surname><given-names>Maryam</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rahmani</surname><given-names>Elham</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Eftekhar</surname><given-names>Tahereh</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="A3">3</xref></contrib><aff id="A1"><label>1</label>Department of Obstetrics and Gynecology, Yazd Research and Clinical Center for Infertility, Shahid Sadoughi
University of Medical Sciences, Yazd, Iran</aff><aff id="A2"><label>2</label>Department of Obstetrics and Gynecology, Bushehr University of Medical Sciences, Bushehr, Iran</aff><aff id="A3"><label>3</label>Department of Obstetrics and Gynecology, Tehran University of Medical Sciences, Tehran, Iran</aff></contrib-group><author-notes><corresp id="cor1">
* Corresponding Address:
<addr-line>P.O.Box: 3631</addr-line><addr-line>Department of Obstetrics and Gynecology</addr-line><institution>Bushehr University of Medical Sciences</institution><addr-line>Bushehr</addr-line><country>Iran</country>
Email: <email>rahmani@bpums.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2012</year></pub-date><pub-date pub-type="epub"><day>17</day><month>12</month><year>2012</year></pub-date><volume>6</volume><issue>3</issue><fpage>175</fpage><lpage>178</lpage><history><date date-type="received"><day>5</day><month>10</month><year>2011</year></date><date date-type="accepted"><day>21</day><month>6</month><year>2012</year></date></history><permissions><copyright-statement>Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited</copyright-statement><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>Human chorionic gonadotropin (HCG), one of the initial embryonic signals, is
probably a major regulator of the embryo-endometrial relationship. This study aims to assess the
advantage of HCG supplementation during the secretory phase of hormonally prepared cycles for
the transfer of cryopreserved-thawed embryos.</p></sec><sec><title>Materials and Methods:</title><p>This study was a randomized clinical trial. Infertile women who were
candidates for frozen-thawed embryo transfers entered the study and were divided into two groups,
HCG and control. The endometrial preparation method was similar in both groups: all women received
estradiol valerate (6 mg) po per day from the second day of the menstrual cycle and progesterone
in oil (100 mg) intramuscular (I.M.) when the endometrial thickness reached 8 mm. Estradiol and
progesterone were continued until the tenth week of gestation. In the HCG group, patients received an
HCG 5000 IU injection on the first day of progesterone administration and the day of embryo transfer.</p></sec><sec><title>Results:</title><p>In this study, 130 couples participated: 65 in the HCG group and 65 in the control group.
There was no statistically significant difference between groups regarding basic characteristics.
Implantation rate, chemical pregnancy, clinical pregnancy, ongoing pregnancy, and abortion rates
were similar in both groups.</p></sec><sec><title>Conclusion:</title><p>Although HCG has some advantages in assisted reproductive technology (ART)
cycles, our study did not show any benefit of HCG supplementation during the secretory phase of
frozen cycles (Registration Number: IRCT201107266420N4).</p></sec></abstract><kwd-group><kwd>ART</kwd><kwd>Implantation</kwd><kwd>Frozen Embryo</kwd><kwd>HCG</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>Citation</meta-name><meta-value>Eftekhar M, Rahmani E, Eftekhar T. Effect of adding human chorionic gonadotropin to the endometrial preparation protocol
in frozen embryo transfer cycles. Int J Fertil Steril. 2012; 6(3): 175-178.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>Introduction</title><p>Implantation is a complex, important process (<xref rid="B1" ref-type="bibr">1</xref> ).
Embryo quality and uterine receptivity are important
factors that influence the outcome of assisted reproductive
technology (ART). Various substances such
as cyclic adenosine monophosphate (cAMP), relaxin,
gonadotropin, prostaglandin E2 (PGE2), and glycoprotein
hormones that are secreted from the embryo
or endometrium affect implantation (<xref rid="B2" ref-type="bibr">2</xref> -<xref rid="B7" ref-type="bibr">7</xref> ). Secretion
of human chorionic gonadotropin (HCG) is one of
the initial embryonic signals. It is probably a major
regulator of the embryo-endometrial relationship.
Expression of the HCG/luteinizing hormone (HCG/
LH) receptor is observed in the endometrium during
the secretory phase of menstrual cycles (<xref rid="B7" ref-type="bibr">7</xref> ). HCG is
usually defined as a key factor that can induce and
develop <italic>in vitro</italic> decasualization of the endometrium
(<xref rid="B6" ref-type="bibr">6</xref> , <xref rid="B8" ref-type="bibr">8</xref> ). HCG may have systemic and local effects on
the embryo-endometrial microenvironment (<xref rid="B9" ref-type="bibr">9</xref> ).</p><p>Pregnancy rates following cryopreserved embryo
transfer cycles are usually lower than fresh
embryo transfer cycles. However, transfer of excess
embryos in frozen cycles increases the cumulative
pregnancy rates and decreases the costs. So
an attempt to evaluate the factors that influence the
success rate of cryopreserved cycles is important
(<xref rid="B9" ref-type="bibr">9</xref> , <xref rid="B10" ref-type="bibr">10</xref> ). The aim of this study is to assess the advantage
of HCG supplementation during the secretory phase of hormonally-prepared cycles for the
transfer of cryopreserved-thawed embryos.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><p>This randomized clinical trial was conducted at
the Yazd Research and Clinical Center for Infertility,
Shahid Sadoughi University of Medical Sciences
between January 2009 and June 2011. The study was
approved by the Ethics Committee of the university.
Written informed consent was obtained from all
couples. Women who had undergone <italic>in vitro</italic> fertilization
(IVF) or intracytoplasmic sperm injection
(ICSI) with cryopreservation of excess embryos and
fresh cycles with implantation failure entered the
study. Women older than 38 years, those with a body
mass index (BMI) &#x0003e;30 kg/m<sup>2</sup>, history of endocrine
disorders, and severe endometriosis were excluded
from the study. The patients were allocated into two
groups: group 1 (HCG) and group 2 (control) as performed
by computerized randomization.</p><p>Morphological assessment of all embryos was
performed on the second day after oocyte retrieval.
We transferred two or three embryos. Any excess
embryos that had less than 30% fragmentation were
frozen by the vitrification method. After a two-step
loading with equilibrant and vitrification solutions,
embryos were loaded by a thin glass capillary on to
the cryoton. After loading, nearly the entire solution
was eliminated and only a fine layer covering the
embryos remained. The embryos were flooded in to
liquid nitrogen, a film part of cryoton was covered
by a plastic cap, and we stored the sample in liquid
nitrogen. Thawing was performed at least two
months after cryopreservation, when straws were
exposed to air and then submerged in water. The
cryoprotectant was eliminated using embryo-thawing
media (Vitrolife). After thawing, the embryos
were transferred to a culture media and evaluated
24 hours later. We selected those embryos with less
than 50% fragmentation for transfer.</p><p>The endometrial preparation process was similar
in both groups. All women received oral estradiol
valerate (2 mg, Aburaihan Co., Tehran, Iran) 6 mg
per day from the second day of the menstrual cycle.
Endometrial thickness was measured by vaginal ultrasonography.
From the 13<sup>th</sup> day of the cycle when
endometrial thickness reached 8 mm, intramuscular
(IM) injections of progesterone in oil (100 mg;
Aburaihan Co., Tehran, Iran) were administered to
all subjects. Embryo transfer was performed three
days after the beginning of progesterone administration.
Estradiol and progesterone were continued
until the tenth week of gestational age.</p><p>In the HCG group, 5000 IU HCG (Pregnyl&#x000ae;, Organon,
Oss, Netherlands) was injected on the first
day of progesterone administration and on the day
of embryo transfer. Embryo thawing was performed
two days after the first progesterone injection. Embryos
were transferred one day after thawing by a
Labotect catheter (Labotect, Gotting, Germany).</p><p>Chemical pregnancy was defined by serum &#x003b2; hCG
&#x0003e;50 IU/L 12 days after embryo transfer and clinical
pregnancy was defined by observation of fetal heart
activity two weeks after positive &#x003b2; hCG. We defined
miscarriage as the loss of pregnancy before the 20<sup>th</sup>
week of gestation and ongoing pregnancy as continuation
of pregnancy after the 12<sup>th</sup> week of gestation.
Implantation rate was defined as the numbers
of gestational sacs per 100 embryos transferred.</p><sec><title>Statistical analysis</title><p>
Statistical analysis was carried out using the statistical
package for the social sciences (SPSS version
15.0 for Windows, Chicago, IL). Both t test
and chi-square test were used to detect significant
differences between two groups. The level of significance
was set at p value&#x0003c;0.05.</p></sec><sec sec-type="results"><title>Results</title><p>In this study, a total of 130 couples participated:
65 in group 1 (HCG group) and 65 in group 2 (control
group). The demographic and basic characteristics
of patients are shown in table 1.</p><p>There were no statistically significant differences
between groups regarding age (p=0.549), duration
of infertility (p=0.368), basal follicle stimulating
hormone (p=0.135), BMI (p=0.661), and etiology
of infertility (p=0.201). The cycle characteristics
and outcome of vitrification are shown in table 2.</p><p>There were no statistically significant differences
between groups regarding the numbers of thawed embryos,
numbers of transferred embryos, survival rates
of thawing embryos and duration of freezing. Table
3 shows the outcome of ART cycles. Implantation,
chemical pregnancy, clinical pregnancy, ongoing pregnancy, and abortion rates were similar in both groups.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Basic patient characteristics in the two groups</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><th rowspan="1" colspan="1">Variables </th><th rowspan="1" colspan="1">HCG group Mean (SD)</th><th rowspan="1" colspan="1">Control group Mean (SD)</th><th rowspan="1" colspan="1">P value</th></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Age (Years)</bold></td><td rowspan="1" colspan="1">28.47 &#x000b1; 4.14</td><td rowspan="1" colspan="1">28.84 &#x000b1; 3.71</td><td rowspan="1" colspan="1">0.549</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Duration of infertility (Years)</bold></td><td rowspan="1" colspan="1">6.58 &#x000b1; 2.9</td><td rowspan="1" colspan="1">6.09 &#x000b1; 2.74</td><td rowspan="1" colspan="1">0.368</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Basal FSH (IU/L)</bold></td><td rowspan="1" colspan="1">5.15 &#x000b1; 1.66</td><td rowspan="1" colspan="1">5.60 &#x000b1; 1.72</td><td rowspan="1" colspan="1">0.135</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>BMI (kg/m<sup>2</sup>)</bold></td><td rowspan="1" colspan="1">23.67 &#x000b1; 2.43</td><td rowspan="1" colspan="1">23.86 &#x000b1; 2.3</td><td rowspan="1" colspan="1">0.661</td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>Etiology of infertility</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ovulatory , n (%)</bold></td><td rowspan="1" colspan="1">13 (20)</td><td rowspan="1" colspan="1">13 (20)</td><td rowspan="1" colspan="1">0.201</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Tubal, n (%)</bold></td><td rowspan="1" colspan="1">9 (13.8)</td><td rowspan="1" colspan="1">10 (15.4)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Unexplained, n (%)</bold></td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1"> 4 (3.1)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Mixed, n (%)</bold></td><td rowspan="1" colspan="1">42 (64.6)</td><td rowspan="1" colspan="1">35 (53.8)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Male, n (%)</bold></td><td rowspan="1" colspan="1">1 (1.5)</td><td rowspan="1" colspan="1">4 (3.1)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Total, n (%)</bold></td><td rowspan="1" colspan="1">63 (100)</td><td rowspan="1" colspan="1">65 (100)</td><td rowspan="1" colspan="1"/></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr></tbody></table></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Cycle characteristics and outcome of vitrification</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><th rowspan="1" colspan="1">Variables</th><th rowspan="1" colspan="1">HCG group Mean (SD)</th><th rowspan="1" colspan="1">Control group Mean (SD)</th><th rowspan="1" colspan="1">P value</th></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Duration of freezing (Months)</bold></td><td rowspan="1" colspan="1">6.58 &#x000b1; 3.1</td><td rowspan="1" colspan="1">6.09 &#x000b1; 2.74 </td><td rowspan="1" colspan="1">0.326</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Number of thawed embryos</bold></td><td rowspan="1" colspan="1">2.96 &#x000b1; 0.17</td><td rowspan="1" colspan="1">2.89 &#x000b1; 0.31</td><td rowspan="1" colspan="1">0.086</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Survival rate after thawing (%)</bold></td><td rowspan="1" colspan="1">91.79 &#x000b1; 0.20 </td><td rowspan="1" colspan="1">94.87 &#x000b1; 0.12</td><td rowspan="1" colspan="1">0.299</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Numbers of transferred embryos</bold></td><td rowspan="1" colspan="1">2.73 &#x000b1; 0.44</td><td rowspan="1" colspan="1">2.60 &#x000b1; 0.49</td><td rowspan="1" colspan="1">0.095</td></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr></tbody></table></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p>ART outcome in both groups</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><th rowspan="1" colspan="1">Variables</th><th rowspan="1" colspan="1">HCG group</th><th rowspan="1" colspan="1">Control group</th><th rowspan="1" colspan="1">P Value</th></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Implantation rate (%)</bold></td><td rowspan="1" colspan="1">21.02 </td><td rowspan="1" colspan="1">17.44</td><td rowspan="1" colspan="1">0.488</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Chemical pregnancy rate, n (%)</bold></td><td rowspan="1" colspan="1">27 (41.5)</td><td rowspan="1" colspan="1">25 (38.5)</td><td rowspan="1" colspan="1">0.429</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Clinical pregnancy rate, n (%)</bold></td><td rowspan="1" colspan="1">22 (30.8)</td><td rowspan="1" colspan="1">20 (30.8.7)</td><td rowspan="1" colspan="1">0.426</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ongoing pregnancy rate, n (%)</bold></td><td rowspan="1" colspan="1">20 (30.8)</td><td rowspan="1" colspan="1">18 (27.7)</td><td rowspan="1" colspan="1">0.424</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Miscarriage rate, n (%)</bold></td><td rowspan="1" colspan="1">7 (25.9)</td><td rowspan="1" colspan="1">7 (28.0.4)</td><td rowspan="1" colspan="1">0.556</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Endometrial thickness (mm)</bold></td><td rowspan="1" colspan="1">8.83&#x000b1;1.6</td><td rowspan="1" colspan="1">9.08&#x000b1;1.2</td><td rowspan="1" colspan="1">0.528</td></tr><tr><th colspan="4" rowspan="1"><hr/></th></tr></tbody></table></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>While treatment protocols, early embryo development,
and laboratory techniques have considerably improved
over the last decades in ART cycles, little has been identified
about the events that occur after the transfer of embryos
in to the uterine cavity. About 75% of embryos do
not implant after transfer. Thus, to improve implantation
rates we need additional understanding of the molecular
mechanisms governing the endometrial preparation for
embryo implantation (<xref rid="B11" ref-type="bibr">11</xref> -<xref rid="B13" ref-type="bibr">13</xref> ).</p><p>According to our data, for better embryo implantation
it is necessary to have a good embryo with appropriate
morphology and developmental potential
as well as a high concentration of HCG. In this study
we have hypothesized that HCG supplementation in
the secretory phase of the endometrium during the
frozen embryo cycle may increase the implantation
and eventually the pregnancy rate. However our findings
have contradicted with this hypothesis.</p><p>Our study showed that HCG supplementation for
endometrial preparation in cryopreserved cycles had
no more benefit than estradiol and progesterone.
Our finding was consistent with the Ben-Meir et al.
study where the researchers observed that recombinant
HCG supplementation during the secretory
phase of the frozen-thawed embryo transfer cycles
showed no advantage in terms of pregnancy and implantation
rates (<xref rid="B9" ref-type="bibr">9</xref> ). Similar to our study, they did
not use a GnRH agonist for down-regulation, and
thus endogenous basal LH secretion was not completely
suppressed. Tesarik et al. (<xref rid="B14" ref-type="bibr">14</xref> ) demonstrated
that HCG supplementation during the luteal phase
of the oocyte donation cycle improved pregnancy
rates only in cycles with low endogenous LH.</p><p>Mansour et al. (<xref rid="B15" ref-type="bibr">15</xref> ) have shown that intrauterine
injection of 500 IU HCG prior to embryo transfer
significantly increased pregnancy rate after ART.
They concluded that the HCG level positively correlated
with the level of trophoblastic tolerance.</p><p>HCG plays a central role in controlling implantation
and early embryonic development (<xref rid="B16" ref-type="bibr">16</xref> ). This hormone
is produced very early by the developing embryo and
is secreted in relatively high concentrations. HCG may
effectively regulate endometrial preparation via the
following processes (<xref rid="B17" ref-type="bibr">17</xref> ): i. local down-regulation of
insulin growth factor binding protein 1 (IGF BP-1)
by HCG leads to the prolongation of the window of
endometrium; ii. HCG augments the endometrial receptivity
by increasing angiogenesis through increased
local vasoendothelial growth factor (VEGF) (<xref rid="B18" ref-type="bibr">18</xref> , <xref rid="B19" ref-type="bibr">19</xref> );
iii.HCG interacts with the production of galactosemic
fibroblast (M-GSF) and leukemia inhibiting factor
(LIF) that are important for implantation (<xref rid="B20" ref-type="bibr">20</xref> ); iv. HCG
significantly inhibits the production of metalloproteinase (<xref rid="B21" ref-type="bibr">21</xref> ); and v. HCG has been demonstrated to have
an impact on the trophoblasts, resulting in improved
differentiation and invasion potential (<xref rid="B7" ref-type="bibr">7</xref> , <xref rid="B22" ref-type="bibr">22</xref> ).</p><p>Fatemi et al. have concluded that the spontaneous
natural cycle is superior to the HCG induced natural
cycle. They showed a negative effect of HCG
administration on pregnancy. These researchers hypothesized
that the significantly lower pregnancy
rate in the HCG group was related to desynchronization
between a receptive endometrium and embryo,
which resulted from the endometrial effects of HCG.
Administration of HCG has been shown to induce
a series of events in the endometrium which begins
several days later. These events may have a negative
impact on implantation (<xref rid="B23" ref-type="bibr">23</xref> ). Additional studies with
larger sample sizes are required for better evaluation.</p></sec></sec><sec sec-type="conclusions"><title>Conclusion</title><p>While HCG has some advantages in the ART cycle,
our study did not show any advantage of HCG supplementation
in the secretory phase of frozen cycles.</p></sec></body><back><ack><p>The authors wish to thank the staff of the Yazd Research
and Clinical Center for Infertility for their cooperation
and also the Shahid Sadoughi University of
Medical Sciences and Health Services for financial
support. There is no conflict of interest in this study.</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Hasani</surname><given-names>S</given-names></name></person-group><article-title>Cancellation of fresh embryo transfer: a future perspective</article-title><source>Int J Fertil Steril</source><year>2011</year><volume>5</volume><issue>Suppl 1</issue><fpage>1</fpage><lpage>5</lpage></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irwin</surname><given-names>JC</given-names></name><name><surname>Kirk</surname><given-names>D</given-names></name><name><surname>King</surname><given-names>RJ</given-names></name><name><surname>Quigley</surname><given-names>MM</given-names></name><name><surname>Gwatkin</surname><given-names>RB</given-names></name></person-group><article-title>Hormonal regulation of human endometrial stromal cells in culture: an in vitro model for decidualization</article-title><source>Fertil Steril</source><year>1989</year><volume>52</volume><issue>5</issue><fpage>761</fpage><lpage>768</lpage><pub-id pub-id-type="pmid">2806617</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>JR</given-names></name><name><surname>Tseng</surname><given-names>L</given-names></name><name><surname>Bischof</surname><given-names>P</given-names></name><name><surname>J&#x000e4;nne</surname><given-names>OA</given-names></name></person-group><article-title>Regulation of prolactin production by progestin, estrogen, and relaxin in human endometrial stromal cells</article-title><source>Endocrinology</source><year>1987</year><volume>121</volume><issue>6</issue><fpage>2011</fpage><lpage>2017</lpage><pub-id pub-id-type="pmid">2960516</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>B</given-names></name><name><surname>Gurpide</surname><given-names>E</given-names></name></person-group><article-title>Direct effect of gonadotropins on decidualization of human endometrial stromal cells</article-title><source>J Steroid Biochem Mol Biol</source><year>1993</year><volume>47</volume><issue>1-6</issue><fpage>115</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">8274425</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>B</given-names></name><name><surname>Guller</surname><given-names>S</given-names></name><name><surname>Gurpide</surname><given-names>E</given-names></name></person-group><article-title>Cyclic adenosine 3', 5'-monophosphate induces prolactin expression in stromal cells isolated from human proliferative endometrium</article-title><source>Endocrinology</source><year>1993</year><volume>133</volume><issue>5</issue><fpage>2197</fpage><lpage>2203</lpage><pub-id pub-id-type="pmid">8404671</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasahara</surname><given-names>K</given-names></name><name><surname>Takakura</surname><given-names>K</given-names></name><name><surname>Takebayashi</surname><given-names>K</given-names></name><name><surname>Kimura</surname><given-names>F</given-names></name><name><surname>Nakanishi</surname><given-names>K</given-names></name><name><surname>Noda</surname><given-names>Y</given-names></name></person-group><article-title>The role of human chorionic gonadotropin on decidualization of endometrial stromal cells in vitro</article-title><source>J Clin Endocrinol Metab</source><year>2001</year><volume>86</volume><issue>3</issue><fpage>1281</fpage><lpage>1286</lpage><pub-id pub-id-type="pmid">11238521</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Licht</surname><given-names>P</given-names></name><name><surname>Fluhr</surname><given-names>H</given-names></name><name><surname>Neuwinger</surname><given-names>J</given-names></name><name><surname>Wallwiener</surname><given-names>D</given-names></name><name><surname>Wildt</surname><given-names>L</given-names></name></person-group><article-title>Is human chorionic gonadotropin directly involved in the regulation of human implantation?</article-title><source>Mol Cell Endocrinol</source><year>2007</year><volume>269</volume><issue>1-2</issue><fpage>85</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">17367920</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Aboulghar</surname><given-names>M</given-names></name><name><surname>Rizk</surname><given-names>B</given-names></name></person-group><source>Ovarian stimulation</source><edition>1th ed</edition><publisher-loc>New York</publisher-loc><publisher-name>Cambridge University Press</publisher-name><year>2011</year><size units="page">151</size></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Meir</surname><given-names>A</given-names></name><name><surname>Aboo-Dia</surname><given-names>M</given-names></name><name><surname>Revel</surname><given-names>A</given-names></name><name><surname>Eizenman</surname><given-names>E</given-names></name><name><surname>Laufer</surname><given-names>N</given-names></name><name><surname>Simon</surname><given-names>A</given-names></name></person-group><article-title>The benefit of human chorionic gonadotropin supplementation throughout the secretory phase of frozen-thawed embryo transfer cycles</article-title><source>Fertil Steril</source><year>2010</year><volume>93</volume><issue>2</issue><fpage>351</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">19342020</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konc</surname><given-names>J</given-names></name><name><surname>Kanyo</surname><given-names>K</given-names></name><name><surname>Varga</surname><given-names>E</given-names></name><name><surname>Kriston</surname><given-names>R</given-names></name><name><surname>Cseh</surname><given-names>S</given-names></name></person-group><article-title>The effect of cycle regimen used for endometrium preparation on the outcome of day 3 frozen embryo transfer cycle</article-title><source>Fertil Steril</source><year>2010</year><volume>94</volume><issue>2</issue><fpage>767</fpage><lpage>768</lpage><pub-id pub-id-type="pmid">19917505</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname><given-names>B</given-names></name><name><surname>Urman</surname><given-names>B</given-names></name></person-group><article-title>Effect of oocyte morphology on embryo development and implantation</article-title><source>Reprod Biomed Online</source><year>2006</year><volume>12</volume><issue>5</issue><fpage>608</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">16790106</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margalioth</surname><given-names>EJ</given-names></name><name><surname>Ben-Chetrit</surname><given-names>A</given-names></name><name><surname>Gal</surname><given-names>M</given-names></name><name><surname>Eldar-Geva</surname><given-names>T</given-names></name></person-group><article-title>Investigation and treatment of repeated implantation failure following IVF-ET</article-title><source>Hum Reprod</source><year>2006</year><volume>21</volume><issue>12</issue><fpage>3036</fpage><lpage>3043</lpage><pub-id pub-id-type="pmid">16905766</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thurin</surname><given-names>A</given-names></name><name><surname>Hardarson</surname><given-names>T</given-names></name><name><surname>Hausken</surname><given-names>J</given-names></name><name><surname>Jablonowska</surname><given-names>B</given-names></name><name><surname>Lundin</surname><given-names>K</given-names></name><name><surname>Pinborg</surname><given-names>A</given-names></name><etal/></person-group><article-title>Predictors of ongoing implantation in IVF in a good prognosis group of patients</article-title><source>Hum Reprod</source><year>2005</year><volume>20</volume><issue>7</issue><fpage>1876</fpage><lpage>1880</lpage><pub-id pub-id-type="pmid">15774540</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesarik</surname><given-names>J</given-names></name><name><surname>Hazout</surname><given-names>A</given-names></name><name><surname>Mendoza</surname><given-names>C</given-names></name></person-group><article-title>Luteinizing hormone affects uterine receptivity independently of ovarian function</article-title><source>Reprod Biomed Online</source><year>2003</year><volume>7</volume><issue>1</issue><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">12930575</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansour</surname><given-names>R</given-names></name><name><surname>Tawab</surname><given-names>N</given-names></name><name><surname>Kamal</surname><given-names>O</given-names></name><name><surname>El-Faissal</surname><given-names>Y</given-names></name><name><surname>Serour</surname><given-names>A</given-names></name><name><surname>Aboulghar</surname><given-names>M</given-names></name><etal/></person-group><article-title>Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study</article-title><source>Fertil Steril</source><year>2011</year><volume>96</volume><issue>6</issue><fpage>1370</fpage><lpage>1374</lpage><pub-id pub-id-type="pmid">22047664</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>A</given-names></name><name><surname>Brachwitz</surname><given-names>N</given-names></name><name><surname>Sohr</surname><given-names>S</given-names></name><name><surname>Engeland</surname><given-names>K</given-names></name><name><surname>Langwisch</surname><given-names>S</given-names></name><name><surname>Dolaptchieva</surname><given-names>M</given-names></name><etal/></person-group><article-title>Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy</article-title><source>J Immunol</source><year>2009</year><volume>182</volume><issue>9</issue><fpage>5488</fpage><lpage>5497</lpage><pub-id pub-id-type="pmid">19380797</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berndt</surname><given-names>S</given-names></name><name><surname>Perrier d'Hauterive</surname><given-names>S</given-names></name><name><surname>Blacher</surname><given-names>S</given-names></name><name><surname>P&#x000e9;queux</surname><given-names>C</given-names></name><name><surname>Lorquet</surname><given-names>S</given-names></name><name><surname>Munaut</surname><given-names>C</given-names></name><etal/></person-group><article-title>Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium</article-title><source>FASEB J</source><year>2006</year><volume>20</volume><issue>14</issue><fpage>2630</fpage><lpage>2632</lpage><pub-id pub-id-type="pmid">17065221</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Licht</surname><given-names>P</given-names></name><name><surname>Russu</surname><given-names>V</given-names></name><name><surname>Lehmeyer</surname><given-names>S</given-names></name><name><surname>M&#x000f6;ll</surname><given-names>J</given-names></name><name><surname>Siebzehnr&#x000fc;bl</surname><given-names>E</given-names></name><name><surname>Wildt</surname><given-names>L</given-names></name></person-group><article-title>Intrauterine microdialysis reveals cycle-dependent regulation of endometrial insulin-like growth factor binding protein-1 secretion by human chorionic gonadotropin</article-title><source>Fertil Steril</source><year>2002</year><volume>78</volume><issue>2</issue><fpage>252</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">12137859</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herr</surname><given-names>F</given-names></name><name><surname>Liang</surname><given-names>OD</given-names></name><name><surname>Herrero</surname><given-names>J</given-names></name><name><surname>Lang</surname><given-names>U</given-names></name><name><surname>Preissner</surname><given-names>KT</given-names></name><name><surname>Han</surname><given-names>VK</given-names></name><etal/></person-group><article-title>Possible angiogenic roles of insulin-like growth factor II and its receptors in uterine vascular adaptation to pregnancy</article-title><source>J Clin Endocrinol Metab</source><year>2003</year><volume>88</volume><issue>10</issue><fpage>4811</fpage><lpage>4817</lpage><pub-id pub-id-type="pmid">14557459</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrier d'Hauterive</surname><given-names>S</given-names></name><name><surname>Charlet-Renard</surname><given-names>C</given-names></name><name><surname>Berndt</surname><given-names>S</given-names></name><name><surname>Dubois</surname><given-names>M</given-names></name><name><surname>Munaut</surname><given-names>C</given-names></name><name><surname>Goffin</surname><given-names>F</given-names></name><etal/></person-group><article-title>Human chorionic gonadotropin and growth factors at the embryonic-endometrial interface control leukemia inhibitory factor (LIF) and interleukin 6 (IL-6) secretion by human endometrial epithelium</article-title><source>Hum Reprod</source><year>2004</year><volume>19</volume><issue>11</issue><fpage>2633</fpage><lpage>2643</lpage><pub-id pub-id-type="pmid">15388676</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Licht</surname><given-names>P</given-names></name><name><surname>Russu</surname><given-names>V</given-names></name><name><surname>Lehmeyer</surname><given-names>S</given-names></name><name><surname>Wildt</surname><given-names>L</given-names></name></person-group><article-title>Molecular aspects of direct LH/hCG effects on human endometrium--lessons from intrauterine microdialysis in the human female in vivo</article-title><source>Reprod Biol</source><year>2001</year><volume>1</volume><issue>1</issue><fpage>10</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">14666171</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Licht</surname><given-names>P</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Lei</surname><given-names>ZM</given-names></name><name><surname>Rao</surname><given-names>CV</given-names></name><name><surname>Merz</surname><given-names>WE</given-names></name></person-group><article-title>Novel selfregulation of human chorionic gonadotropin biosynthesis in term pregnancy human placenta</article-title><source>Endocrinology</source><year>1993</year><volume>133</volume><issue>6</issue><fpage>3014</fpage><lpage>3025</lpage><pub-id pub-id-type="pmid">8243330</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>HM</given-names></name><name><surname>Kyrou</surname><given-names>D</given-names></name><name><surname>Bourgain</surname><given-names>C</given-names></name><name><surname>Van den Abbeel</surname><given-names>E</given-names></name><name><surname>Griesinger</surname><given-names>G</given-names></name><name><surname>Devroey</surname><given-names>P</given-names></name></person-group><article-title>Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle</article-title><source>Fertil Steril</source><year>2010</year><volume>94</volume><issue>6</issue><fpage>2054</fpage><lpage>2058</lpage><pub-id pub-id-type="pmid">20097333</pub-id></element-citation></ref></ref-list></back></article>